Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible Meeting Abstract


Authors: Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; Robson, M.; Drullinsky, P.; Moynahan, M.; Van Poznak, C.; Panageas, K.; Smith, M.; Norton, L.; Hudis, C.; George, R.
Abstract Title: Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
Meeting Title: 28th Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Breast Cancer Research and Treatment
Volume: 94
Issue: Suppl. 1
Meeting Dates: 2005 Dec 8-11
Meeting Location: San Antonio, TX
ISSN: 0167-6806
Publisher: Springer  
Date Published: 2005-12-01
Start Page: S108
Language: English
ACCESSION: WOS:000233407100289
PROVIDER: wos
PUBMED: 16374922
DOI: 10.1007/s10549-005-1234-6
Notes: --- - Meeting Abstract 2069 - 28th Annual San Antonio Breast Cancer Symposium - DEC 08-11, 2005 - San Antonio, TX - "1" - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Lisa Smith
    12 Smith
  2. Andrew D Seidman
    318 Seidman
  3. Mary Ellen Moynahan
    105 Moynahan
  4. Clifford Hudis
    905 Hudis
  5. Larry Norton
    758 Norton
  6. Nancy T Sklarin
    54 Sklarin
  7. Mark E Robson
    676 Robson
  8. Chau Dang
    271 Dang
  9. Diana E Lake
    89 Lake
  10. Monica Nancy Fornier
    158 Fornier
  11. Katherine S Panageas
    512 Panageas
  12. Roshini George
    7 George
  13. Odette Marsinay Smith
    98 Smith